The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures by Szyndler, J. et al.
BASIC NEUROSCIENCES, GENETICS AND IMMUNOLOGY - ORIGINAL ARTICLE
The effects of electrical hippocampal kindling of seizures on amino
acids and kynurenic acid concentrations in brain structures
J. Szyndler • P. Maciejak • D. Turzyn ´ska •
A. Sobolewska • J. Walkowiak • A. Płaz ´nik
Received: 18 February 2011/Accepted: 8 August 2011/Published online: 23 August 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Our study demonstrated that the development
of seizures during the electrically induced kindling of sei-
zures is associated with signiﬁcant changes in the con-
centration of kynurenic acid (KYNA) and its precursor,
tryptophan (TRP). The primary ﬁnding of our study was an
increase in KYNA levels and the KYNA/TRP ratio (a
theoretical index of activity of the kynurenine pathway) in
the amygdala and hippocampus of kindled animals. We
also found decreases in the concentration of tryptophan in
the hippocampus and prefrontal cortex. Changes in the
concentration of KYNA and TRP in the amygdala were
accompanied by a signiﬁcant decrease in c-Aminobutryic
Acid (GABA) levels and an increase in the glutamate/
GABA ratio. Moreover, we found a signiﬁcant negative
correlation between the local concentrations of KYNA and
glutamate in the amygdala of kindled rats. However, there
were no changes in the local concentrations of the fol-
lowing amino acids: glutamate, aspartate, glutamine, gly-
cine, taurine and alanine. In conclusion, these new results
suggest a modulatory inﬂuence of KYNA on the process of
epileptogenesis, characterized by a negative relationship
between the KYNA and glutamate systems in the
amygdala.
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Introduction
Kindling of seizures, an animal model of temporal lobe
epilepsy, was used to study the effects of repeated elec-
trical stimulation on brain function. Repeated subthreshold
brain stimulations gradually reduce the seizure threshold,
culminating in tonic–clonic seizures. Electric stimulation is
usually applied to certain brain areas, such as the amyg-
dala, the hippocampus, the perforant path or the piriform
cortex. Kindling can also be induced by the repeated
administration of subthreshold doses of chemoconvulsants,
such as pentylenetetrazol (PTZ) or picrotoxin.
Excessive activation of the excitatory pathways in the
brain, including glutamate transmission and an imbalance
between neuronal excitation and inhibition, is believed to
be the contributing mechanism involved in epileptogenesis.
It is well known that overactivated glutamate receptors
participate in both the initiation and spread of epileptiform-
like activity after kindling (McNamara et al. 1988).
Moreover, N-methyl-D-aspartate (NMDA) receptor antag-
onists are effective anticonvulsants (Wong et al. 1986).
Thus, it is commonly believed that overstimulated gluta-
matergic transmission, mediated primarily through the
NMDA and other glutamatergic ionotropic receptors, sig-
niﬁcantly contributes to the development of the kindling
phenomenon (McNamara et al. 1988).
Similar to GABA and glycine, kynurenic acid (KYNA)
is thought to be one of the most important endogenous
inhibitory neuroactive metabolites controlling the kindling
process and seizures (Turski et al. 1988, 1989, 1990).
KYNA is synthesized from tryptophan by astrocytes and
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l-kynurenine by four kynurenine aminotransferases in the
kynurenine pathway (KAT I–IV) (Kiss et al. 2003).
KYNA is an endogenous antagonist of glutamate
NMDA receptors (Erhardt et al. 2009). It also acts as a
competitive antagonist at AMPA and kainate receptors and
non-competitively blocks presynaptic a7 nicotinic acetyl-
choline receptors (a7 nAChRs), regulating glutamate
release (Fu et al. 2000; Harris et al. 1998; Hilmas et al.
2001). A growing body of evidence suggests that KYNA is
an important endogenous neuroprotective agent and that it
prevents neuronal loss following various neuronal injuries,
including excitotoxic or ischemia-induced damage (Cozzi
et al. 1999; Sas et al. 2007). Recently, Rozsa et al. (2008)
demonstrated that the application of l-kynurenine led to the
inhibition of PTZ-induced discharges in hippocampal sli-
ces in vitro (Rozsa et al. 2008).
In addition, there are data indicating that the concen-
tration of KYNA in the brain is altered in epilepsy. How-
ever, the nature and time response of changes in KYNA
concentration and the relation of KYNA levels to the
concentrations of other amino acids, including its precur-
sor, tryptophan, are not elucidated (Heyes et al. 1994). It is
particularly important to determine the possible role of an
interaction between amino acids in cortical and limbic
brain structures. The pivotal role of the hippocampus,
amygdala and prefrontal cortex in epilepsy prompted the
examination of changes in the concentration of KYNA and
amino acids, including tryptophan, in these brain structures
in rats subjected to electrically induced hippocampal
kindling.
Methods
Animals
Twenty 12-week-old adult male Wistar rats weighing
220 ± 20 g were used in the study. Two rats were housed
per cage under standard laboratory conditions with a 12-h
photocycle (lights on at 7:00 a.m.), controlled temperature
(20 ± 2C) and humidity (70%) and free access to food
and water. Experiments were performed between 9:00 a.m.
and 3:00 p.m. The study was conducted in accordance with
the European Communities Council Directive of 24
November 1986 (86/609/EEC) and was approved by the
Committee for Animal Care and Use at the Medical Uni-
versity in Warsaw (Protocol No. 17/2006).
Surgical implantation of electrodes
After acclimatization to the laboratory conditions for a
period of one week, the rats were anaesthetized with an
intraperitoneal (i.p.) injection of ketamine 75 mg/kg
(Ketanest, Parke Davis), and sodium pentobarbital 20 mg/
kg (Morbital, Biovet).
One tri-polar electrode (MS333/1; Plastics One, USA)
was implanted into the dorsal hippocampus of each rat using
standard stereotaxic techniques. Two twisted stainless-steel
wiresimplantedintothehippocampusservedasstimulation/
recordingelectrodes.Thedistancebetweentheelectrodetips
was approximately 500 lm. One stainless steel wire, con-
nected to a metal screw located over the parietal cortex, was
used as a neutral electrode. All electrodes were implanted
into the left or right dorsal hippocampus. The stereotaxic
coordinates of the hippocampal implantation were (from the
skull surface): bregma (-)2.4 mm, lateral 2.0 mm and
ventral 3.5 mm (Fig. 1a; Paxinos and Watson 1998). The
electrodes were held in place with dental acrylic cement
applied to the exposed skull surface.
Kindling and electroencephalographic (EEG) recording
Electrical stimulation of the hippocampus was initiated
2 weeks after surgery. The kindling stimuli were delivered
daily for 5 days a week. Stimulations were performed by a
Grass Model S88 stimulator connected to a constant-cur-
rent unit (CCU1) and a stimulus-isolated unit (SIU5 RF;
Grass Instruments). The kindling stimulus consisted of a
1-s train of 60 Hz and 1-ms monophasic square-wave
pulses at an intensity of 500 lA until at least two con-
secutive fully kindled stage 5 seizures were elicited. The
seizures were classiﬁed according to the Racine scale as
follows: Stage 1, jaw clonus; Stage 2, head nodding; Stage
3, forelimb clonus; Stage 4, rearing on the hind limbs; and
Stage 5, loss of postural control, tonic-clonic seizures
(Racine et al. 1972). The number of stimulations necessary
to achieve stage 5 seizures ranged between 45 and 60.
Following each stimulation, the seizure stage and presence
of afterdischarges (ADs) were recorded. A stimulation/
recording switching unit (Grass Instruments) with the
ability to choose the mode of operation (record or stimu-
lation) was used. A Grass PolyVIEW16 data acquisition
and analysis system (Grass Instruments) was used to record
electroencephalographic (EEG) activity. Before the signal
was recorded, it was ampliﬁed by the high performance
ampliﬁer 15A54 (Grass Instruments). An AD was deﬁned
as ‘‘spike’’ activity in the EEG (Fig. 1b), with an amplitude
of at least twice the baseline activity and a duration of at
least 5 s. One-and-a-half hours after the ﬁnal stimulation,
the kindled and control animals (sham stimulated rats,
which had been implanted with electrodes and subjected to
all experimental details) were killed, and their brains were
removed, frozen at -70C and cut into slices (1 mm thick).
The prefrontal cortex [bregma (?)0.7], amygdala and
hippocampus [bregma (-)3.6] were removed from the
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123brain slices (within their deﬁned anatomical limits) using a
scalpel and then placed onto ice-cold Petri dishes aided by
a magnifying glass. The amino acid composition and
concentration of KYNA in these anatomical structures
were subsequently analyzed.
Determination of kynurenic acid concentration in brain
homogenates
To determine kynurenic acid (KYNA) and tryptophan
(TRP) concentrations, each tissue sample was weighed,
placed in a cool, dry polypropylene vial, and homogenized
in 20 volumes of ice-cold 2% perchloric acid (30 s at 4C).
The homogenates were then centrifuged at 26,8809g for
8 min at 4C. After centrifugation, the supernatants were
collected and ﬁltered through 0.45 lm ﬁlter (Millipore).
Samples were immediately frozen and kept at -70C until
they were assayed. Kynurenic acid and tryptophan brain
concentrations were measured according to the modiﬁed
methods of Wu et al. (1992) and Herve et al. (1996). The
detection of KYNA and tryptophan was performed by
high-performance liquid chromatography (HPLC) with
ﬂuorescence detection. The HPLC system used for the
analysis consisted of the following components: a pump
(Shimadzu, LC-10AD VP) and a ﬂuorescence detector
(Shimadzu, RF-10 XL). The ﬂuorescence detector was set
at an excitation wavelength of 344 nm and emission
wavelength of 398 nm for the detection of KYNA, and 404
and 504 nm for the detection of TRP. Supernatant samples
were injected manually via a Rheodyne 7725i injection
valve with a 20 ll sample loop. KYNA and TRP were
separated on a Phenomenex Luna C18 (150 mm 9 3 mm)
column with a Phenomenex KJO-4286 precolumn set at a
ﬂow rate of 0.4 ml/min operating at room temperature. The
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Fig. 1 a Histological
micrograph showing electrode
placement. An arrow indicates
the electrode tract. The slice
was photographed with a 94
objective lens and then
magniﬁed digitally.
b Representative EEG recording
from the hippocampus of an
animal with stage 5 seizure after
hippocampal electrical
stimulations (1-s train of 60 Hz
1-ms monophasic square-wave
pulses at an intensity of 500 lA)
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123mobile phase (isocratic system) consisted of 50 mM
sodium acetate, 250 mM zinc acetate and 4% acetonitrile
(adjusted with acetic acid to pH 6.2) and was degassed for
15 min. Chromatogram registration and analysis were
performed using ChromaX 2004 software. The retention
time of KYNA and tryptophan under these conditions was
9 and 17 min, respectively. Calibration curves were created
by injecting KYNA and TRP standards in concentrations
ranging from 0.5 to 120 nM and 0.5–20 lM, respectively.
The concentrations of KYNA and TRP were calculated as
pmol/g of tissue or nmol/g of tissue respectively.
Determination of amino acids in homogenates
For determination of amino acids, each tissue sample was
weighed, placed in a cool, dry polypropylene vial, and
homogenized in 20 volumes of ice-cold 2% perchloric acid
for 30 s at 4C. The homogenates were then centrifuged at
26,8809g for 8 min at 4C. After centrifugation, the
supernatants were collected and ﬁltered through a 0.45 lm
ﬁlter (Millipore). Samples were immediately frozen and
kept at -70C until assayed. The concentrations of amino
acids (glutamate, GABA, alanine, glutamine, glycine,
aspartate, taurine and the glutamate to GABA ratio) were
determined by high performance liquid chromatography
(HPLC), with electrochemical detection (Shimadzu) after a
derivatization procedure, as described previously (Szyndler
et al. 2008). Shortly thereafter, compounds were eluted
isocratically with the mobile phase delivered at 0.70 ml/
min using a Shimadzu Class VP LC 10 AD pump.
A Rheodyne injection valve with a 20 ll sample loop was
used to manually inject the samples. The preparation of the
mobile phase and the derivatizing agents were based on a
method by Rowley et al. (1995), with modiﬁcations. The
mobile phase consisted of 45 mM disodium phosphate and
0.15 mM EDTA with 25% (v/v) methanol adjusted to pH
3.9 using 0.2 M citric acid. To obtain agents for derivati-
zation, OPA (2 mg, Fluka, Germany) was dissolved in
0.5 ml 1 M Na2SO3, 0.5 ml methanol, and 0.9 ml sodium
tetraborate buffer (0.1 M) adjusted to pH 10.4 with 5 M
sodium hydroxide. The concentrations of amino acids were
calculated as lmol/g of brain tissue.
Statistics
The statistical package, Statistica for Windows Release 8
(StatSoft Inc., USA), was used for statistical analysis. The
differences in amino acid and KYNA concentrations among
the experimental groups (kindled vs. controls) were ana-
lyzed with the Student’s t test. The correlation between the
concentration of amino acids and KYNA in the same ani-
mals was performed usingPearson’srcorrelationtest;acut-
off of P\0.05 was used to indicate statistical signiﬁcance.
Results
Student’s t test revealed that in the amygdala the fully
kindled rats showed a signiﬁcantly decreased concentration
of GABA (t = 2.55, P = 0.024) and an increased GLU/
GABA ratio (t = 3.26, P = 0.006) (Fig. 2a). The con-
centration of KYNA (t = 4.03, P = 0.001) and the
KYNA/TRP ratio (t = 3.88, P = 0.001) were increased
compared to the control group (Fig. 2b). In the hippo-
campus, an increased concentration of KYNA (t = 2.41,
P = 0.027) and KYNA/TRP ratio (t = 2.69, P = 0.016),
as well as a decreased concentration of tryptophan
(t = 2.32, P = 0.033), were found (Fig. 3b). In the pre-
frontal cortex of the fully kindled rats, only a decrease in
the concentration of tryptophan (t = 3.24, P = 0.005,
Fig. 4b) was apparent. No changes in the local concentra-
tions of other amino acids (aspartate, glutamine, glycine,
taurine and alanine) were present (Figs. 2a, 3a, 4a). In the
current study, we found a signiﬁcant negative correlation
between the local concentrations of KYNA and glutamate
in the amygdala of kindled rats (r =- 0.7; P\0.05). No
other signiﬁcant correlations between KYNA and amino
acid concentrations were observed.
Discussion
Our study demonstrated that the development of seizures
during the electrically induced hippocampal kindling of
seizures is associated with signiﬁcant changes in the con-
centration of KYNA and its precursor, tryptophan. Thus, the
new ﬁnding of our study indicates that an increase in KYNA
levels and the KYNA/TRP ratio (a theoretical index of
activity of kynurenine pathway) occurred in the amygdala
and hippocampus of kindled animals. We also found that
the tryptophan concentration in the hippocampus and pre-
frontal cortex decreased. Changes in the amygdala con-
centration of KYNA and TRP were accompanied by a
signiﬁcant decrease in GABA levels and an increase in the
GLU/GABA ratio. A signiﬁcant negative correlation
between the concentrations of KYNA and glutamate in the
amygdala of kindled rats was found. There were no changes
in the concentrations of the following amino acids: gluta-
mate, aspartate, glycine, glutamine, taurine and alanine.
Our study indicated that the process of kindling
increases the activity of the kynurenine pathway of tryp-
tophan metabolism. This may account for the increase in
the KYNA concentration and the KYNA/TRP ratio as well
as the decrease in tryptophan levels. In a previous study,
KYNA levels in electrically kindled animals were also
found to be increased in the hippocampus (Wu et al. 1995).
The increase in KYNA levels in the extracellular ﬂuid
(ECF) was not dependent on electrical stimulation per se
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123but on the process of kindling development and neuronal
and/or astrocytic reorganization (Wu et al. 1995). In con-
trast, Lo ¨scher et al. (1996) demonstrated that there were no
signiﬁcant changes in brain tissue KYNA concentrations,
with the exception of the nucleus accumbens, where
kindling induced a lasting increase in kynurenate.
Recently, we reported a signiﬁcant decrease in tissue
KYNA concentrations in some brain structures (the caudate
putamen, entorhinal cortex, piriform cortex, amygdala and
hippocampus) after PTZ-induced kindling (Maciejak et al.
2009).
Previously, using several models of epilepsy, it was
demonstrated that chemoconvulsant-induced seizures
(including PTZ) are associated with an immediately
occurring release and long-lasting elevation of extracel-
lular KYNA levels (Wu and Schwarcz 1996). Given that
PTZ has a very short half-life, the reported biochemical
effect was likely not due to its direct inﬂuence on the
KYNA metabolism but was the result of PTZ-induced
seizures. Of note, the electrical stimulation by depolar-
ization stimulates, in a nonspeciﬁc manner, all neuronal
systems, and astrocytes in the epileptic focus. The initial
mechanism of PTZ action involves only a single GAB-
Aergic neurotransmitter system. Hence, it is possible that
the repeated blockade of GABA-A receptors located on
neurons and astrocytes could lead to the other adaptive
biochemical effects in comparison with electrical brain
stimulation. Furthermore, it is conceivable that, while
acute seizures should increase the ECF concentration of
KYNA, repeated brain stimulation could lead to the
depletion of KYNA tissue stores. The present ﬁndings
indicate, however, that, contrary to this assumption,
chronic electrical stimulation of the hippocampus led to
the increase in tissue KYNA concentration. These ﬁndings
suggest that changes in KYNA levels may depend on the
model of temporal lobe epilepsy (chemically or electri-
cally induced) and the time of biochemical analysis in
relation to the seizure episode.
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Fig. 2 a Concentration of
taurine (TAU), glutamine
(GLM), glycine (GLY),
aspartate (ASP), glutamate
(GLU), alanine (ALA) and
GABA and the GLU/GABA
ratio in the amygdala.
b Concentration of kynurenic
acid (KYNA) and tryptophan
(TRP) and the KYNA/TRP ratio
in the kindled rats. The ratio
(KYNA/TRP) was multiplied by
1,000 to adjust the result to the
log scale of the ﬁgure. The
number of rats in the
experimental groups varied
from 8 to 10. Data represent the
mean ± SEM. *Differs from
the control group. *P\0.05;
**P\0.01; ***P\0.005
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123Brain KYNA concentration may be regulated by several
of the following mechanisms: the uptake of tryptophan
and kynurenine (precursors of KYNA); the activity of in-
doleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-
dioxygenase (TDO), which are enzymes responsible for the
rate-limiting degradation of tryptophan to kynurenine; the
efﬁciency of the transamination of kynurenine to KYNA by
KAT; and the liberation of KYNA from the synthesis
origin (Wu et al. 1995). The exact mechanism of the
alterations in brain KYNA levels during electrical kindling
was not fully elucidated. It has been suggested that the
lasting elevation of KYNA levels in fully kindled animals
appears to be different from the increase that occurs
immediately following generalized convulsions and may
include a desensitization of presynaptic glial amino acid
receptors, regulating local KYNA release, in response to
repeatedly occurring glutamate release (Wu and Schwarcz
1996).
There is strong evidence that KYNA affects the devel-
opment of kindled seizures. Thompson et al. (1988) dem-
onstrated that intracerebroventricular administration of
KYNA (360 nmol) prior to the administration of the
electrical kindling stimulus signiﬁcantly reduced the rate of
kindling (Thompson et al. 1988). Similarly, a signiﬁcant
increase in KYNA levels in the brain, evoked by the
administration of kynurenine hydroxylase and kynureni-
nase inhibitors, protected rats from maximal electroshock-
induced seizures or from audiogenic seizures in DBA/2
mice (Carpenedo et al. 1994). An increase in KYNA
concentration was observed one week after status epilep-
ticus as well as in the extracellular ﬂuid in the fully kindled
animals in vivo 1 week after the last stimulation (Du et al.
1993; Wu et al. 1995). Simultaneously, there were no
changes in the KYNA levels in the animals with stage 2
kindled seizures. Considering the afterdischarges duration
did not differ in animals with stage 2 and in the fully
kindled animals, it appeared that the increase in KYNA in
the fully kindled animals was not simply a consequence of
electrical activity. Mechanisms responsible for this KYNA
increase were not clear (Wu et al. 1995). Some studies
indicated astrocytic hypertrophy in brain structures (e.g. in
the hippocampal formation) during the kindling of seizures
and, as a result, an increase in the activity of KAT, the
primary enzyme responsible for KYNA synthesis (Wu
et al. 1995). Thus, the process of kindling and astrocytic
changes was accompanied by an increase in KYNA (Du
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Fig. 3 a Concentration of
taurine (TAU), glutamine
(GLM), glycine (GLY),
aspartate (ASP), glutamate
(GLU), alanine (ALA) and
GABA and the GLU/GABA
ratio in the hippocampus.
b Concentration of kynurenic
acid (KYNA) and tryptophan
(TRP) and the KYNA/TRP ratio
in the kindled rats. The ratio
(KYNA/TRP) was multiplied by
1,000 to adjust the result to the
log scale of the ﬁgure. The
number of rats in the
experimental groups varied
from 8 to 10. Data represent the
mean ± SEM. *Differs from
control group. *P\0.05
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123et al. 1993). Hypertrophy of astrocytes is likely elicited by
neuronal injury because highly hypertrophied astrocytes
were found in brain areas where neurodegeneration
occurred. However, it should be noted that Wu et al. (1995)
reported no signiﬁcant changes in KAT activity in the
amygdala of animals that were electrically kindled (Wu
et al. 1995).
In our work, we sought to determine whether changes in
KYNA levels were associated with changes in tryptophan
metabolism. Biochemical analysis demonstrated that an
increase in KYNA levels in the hippocampus was accom-
panied by a decrease in tryptophan concentration and an
increase in the KYNA/TRP ratio. These data suggested that
the kynurenine pathway was signiﬁcantly activated during
kindling; however, the exact mechanism responsible for
this phenomenon is difﬁcult to pinpoint. The increase in
KYNA could be related to many of the aforementioned
factors occurring in parallel (changes in synthesis, degra-
dation, or release). Further studies on changes in the
activity of the kynurenine pathway are warranted to clarify
the intrinsic mechanisms of this phenomenon. This
becomes particularly important in light of our recent data
(unpublished), which demonstrated that an important and
widely used antiepileptic drug, valproic acid, given at a
dose of 400 mg/kg to rats fully inhibited PTZ-induced
seizures (50 mg/kg, i.p.) and caused more than a tenfold
increase in the ECF concentration of KYNA (in vivo).
Furthermore, there is evidence suggesting that an increase
in KYNA concentration, evoked by the administration of
kynurenine hydroxylase inhibitors, exerts an important
neuroprotective action that prevents neuronal loss follow-
ing ischemia (Cozzi et al. 1999). The neuroprotective
potency of KYNA may be due to its antagonist actions at
glutamate receptors or the blockade of glutamate release by
the inhibition of presynaptic a7 nAChRs in glutamatergic
terminals (Fu et al. 2000; Hilmas et al. 2001; Harris et al.
1998; Cozzi et al. 1999).
In our study, we also found a decrease in GABA levels
and an increase in the glutamate/GABA ratio in the
amygdala. This ﬁnding suggested that changes in local
KYNA levels may be an adaptive reaction to the disrupted
balance between the primary inhibitory and excitatory
brain systems. The function of the GABA system can be
substantially modiﬁed by seizures, and both the stimulation
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taurine (TAU), glutamine
(GLM), glycine (GLY),
aspartate (ASP), glutamate
(GLU), alanine (ALA), and
GABA and the GLU/GABA
ratio in the prefrontal cortex.
b Concentration of kynurenic
acid (KYNA) and tryptophan
(TRP) and the KYNA/TRP ratio
in the kindled rats. The ratio
(KYNA/TRP) was multiplied by
1,000 to adjust the result to the
log scale of the ﬁgure. The
number of rats in the
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123and the inhibition of local GABAergic activity in response
to kindling has been reported (Kamphuis et al. 1990; Kaura
et al. 1995). Recently, we found that PTZ-induced kindling
reduced the extracellular levels of GABA (in vivo) in the
rat hippocampus (Szyndler et al. 2008). The data presented
here conﬁrmed the previous ﬁndings of our group and
others, which indicated that the imbalance between gluta-
matergic, GABAergic, and KYNA synaptic transmission
characterizes hyperexcitable, epileptic and local neuronal
circuits. According to this suggestion, we found a signiﬁ-
cant negative correlation between the local concentration
of KYNA and glutamate in the amygdala of kindled rats.
More experiments are needed to elucidate the problem of a
contribution of KYNA to the process of epileptogenesis.
For example, it would be of interest to repeat the kindling
procedure in rats given a low tryptophan diet. Would the
lack of an increase in KYNA speciﬁcally affect kindling
and would it simultaneously compensate for the increase in
GABA concentration?
Also worth mentioning is the fact that tryptophan is
the precursor not only of KYNA but of several other
neuroactive substances like serotonin and melatonin.
Moreover, the effects of 5-HT on neuronal excitability
depend on which 5-HT receptors are activated. In this
context, one ought to notice earlier studies performed
with the help of in situ microvoltametry and neuromo-
lecular imaging using the resected tissue samples
obtained from patients with mesial (MTLE) and neo-
cortical temporal lobe epilepsy (NTLE). The authors
found in granular cells and pyramidal layer of dentate
gyrus, in contrast to our study, that L-tryptophan con-
centrations were signiﬁcantly higher in MTLE patients in
comparison with NTLE patients (Pacia and Broderick
2005), while 5-HT concentrations were higher in NTLE
versus MTLE (Broderick et al. 2000). Although, these
clinical data cannot be directly compared with the cur-
rent results, all these ﬁndings indicate that L-tryptophan
metabolism may lead to the formation of various cen-
trally active substances with pro- and anticonvulsant
properties, thus contributing to the pathogenesis of dif-
ferent types of epilepsy.
In conclusion, the results presented here provide support
for the modulatory role of KYNA during the kindling of
seizures in limbic structures. These new results suggest an
activation of the kynurenine pathway in the brain. The
potential participation of KYNA in the process of epilep-
togenesis was demonstrated by a negative relationship
between KYNA and glutamate levels in the amygdala.
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